ストックスクリーナーアプリを入手
86.74
0.54%
0.47
アフターアワーズ：
86.74
前日終値:
$86.27
開ける：
$86.16
24時間の取引高:
355.85K
Relative Volume:
0.34
時価総額：
$6.47B
収益：
-
当期純損益:
$-255.84M
株価収益率:
-20.58
EPS:
-4.2149
ネットキャッシュフロー:
$-232.60M
1週間 パフォーマンス:
+3.25%
1か月 パフォーマンス:
+20.64%
6か月 パフォーマンス:
+60.72%
1年 パフォーマンス:
+172.77%
1日の値動き範囲:
$85.15
$88.99
1週間の範囲:
$81.27
$88.99
52週間の値動き範囲:
$31.21
$88.99
Apogee Therapeutics Inc Stock (APGE) Company Profile
Compare APGE vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
86.74 | 6.44B | 0 | -255.84M | -232.60M | -4.2149 |
VRTX
Vertex Pharmaceuticals Inc
|
440.05 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.46 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
809.27 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.00 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
305.64 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-18 | 開始されました | Truist | Hold |
| 2026-01-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-07 | 開始されました | Wolfe Research | Peer Perform |
| 2025-12-17 | 開始されました | Stephens | Overweight |
| 2025-12-10 | 開始されました | Deutsche Bank | Buy |
| 2025-11-03 | 開始されました | Craig Hallum | Buy |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-07-07 | 繰り返されました | BTIG Research | Buy |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2024-11-25 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-10 | 開始されました | BofA Securities | Buy |
| 2023-12-20 | 開始されました | BTIG Research | Buy |
| 2023-08-08 | 開始されました | Guggenheim | Buy |
| 2023-08-08 | 開始されました | Jefferies | Buy |
| 2023-08-08 | 開始されました | Stifel | Buy |
| 2023-08-08 | 開始されました | TD Cowen | Outperform |
| 2023-08-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Apogee Therapeutics Inc (APGE) 最新ニュース
Apogee Therapeutics Insider Sold Shares Worth $1,651,664, According to a Recent SEC Filing - Moomoo
Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN
How Investors May Respond To Apogee Therapeutics (APGE) CEO Share Sale and US$403 Million Equity Raise - Sahm
Aug PreEarnings: Will Apogee Therapeutics Inc benefit from seasonalityPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn
Dow Update: Should value investors consider Apogee Therapeutics IncQuarterly Market Summary & Accurate Technical Buy Alerts - baoquankhu1.vn
Apogee Therapeutics CEO Henderson sells $1.65 million in stock By Investing.com - Investing.com Australia
Apogee Therapeutics CEO Henderson sells $1.65 million in stock - Investing.com
Apogee Therapeutics (APGE) CEO sells 20,000 shares under Rule 10b5-1 plan - Stock Titan
Apogee Therapeutics stock hits all-time high at 85.95 USD By Investing.com - Investing.com Australia
Apogee Therapeutics stock hits all-time high at 85.95 USD - Investing.com
T. Rowe Price (APGE) discloses 10.29M shares, 16.8% stake in Apogee - Stock Titan
Trade Recap: Whats the beta of Apogee Therapeutics Inc stockWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
APGE Earnings History & Surprises | EPS & Revenue Results | APOGEE THERAPEUTICS INC (NASDAQ:APGE) - ChartMill
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Apogee Therapeutics (APGE) CMO sells shares worth $466,619 By Investing.com - Investing.com Canada
Apogee Therapeutics (APGE) CMO sells shares worth $466,619 - Investing.com
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat
Apogee Therapeutics (APGE) CMO trades 5,500 shares under 10b5-1 plan - Stock Titan
Responsive Playbooks and the APGE Inflection - Stock Traders Daily
APGE Technical Analysis & Stock Price Forecast - Intellectia AI
Mizuho Initiates Coverage of Apogee Therapeutics (APGE) with Outperform Recommendation - MSN
Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics CMO sells $361,860 in shares - Investing.com
Deutsche Bank Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $118 - Moomoo
SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE - marketbeat.com
Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus
Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week HighHere's What Happened - MarketBeat
Apogee Therapeutics prices upsized $350M offering at $70 a share - MSN
BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $137 - Moomoo
APGE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Market Rankings: Will Apogee Therapeutics Inc benefit from seasonalityEarnings Recap Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Should Apogee Therapeutics’ (APGE) Infrequent-Dosing AD Data and $403M Equity Raise Require Investor Action? - simplywall.st
BTIG reiterates Buy on Apogee Therapeutics stock, $137 target By Investing.com - Investing.com South Africa
BTIG reiterates Buy on Apogee Therapeutics stock, $137 target - Investing.com
Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $110.00 at Mizuho - MarketBeat
Mizuho raises Apogee Therapeutics stock price target on AD data By Investing.com - Investing.com South Africa
Mizuho raises Apogee Therapeutics stock price target on AD data - Investing.com
Mizuho Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $110 - Moomoo
Apogee Therapeutics announces $300 million public offering - MSN
Apogee Therapeutics Inc (APGE) 財務データ
収益
当期純利益
現金流量
EPS
2.62%
2.37%
大文字化:
|
ボリューム (24 時間):